This topic contains a solution. Click here to go to the answer

Author Question: The client has been ordered to be treated with belladonna tincture. Which aspect of the client's ... (Read 68 times)

dmcintosh

  • Hero Member
  • *****
  • Posts: 517
The client has been ordered to be treated with belladonna tincture. Which aspect of the client's history would cause the nurse to contact the physician?
 
  a. Urinary retention
  b. Anxiety
  c. Pancreatitis
  d. Peptic ulcer

Question 2

A client complains of flatulence, belching, and abdominal distention. What is the most appropriate drug to use to treat these symptoms?
 
  a. Promethazine (Phenergan)
  b. Ondansetron (Zofran)
  c. Ranitidine (Zantac)
  d. Simethicone (Mylicon)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mcarey591

  • Sr. Member
  • ****
  • Posts: 365
Answer to Question 1

ANS: A
Belladonna tincture is contraindicated when the client has urinary retention.

Answer to Question 2

ANS: D
Simethicone is used to reduce the gastric symptoms of flatulence, belching, and abdominal distention.





 

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library